Press Releases

Press Release 2/2012

Curetis AG Initiates Prospective Clinical Trial for Rapid Pneumonia Diagnostics

Expected CE-marking and launch in Europe in 2012

read more

Press Release 12/2011

Curetis AG Appoints Dr. Klaus Brinkmann as Director of Sales

Preparation of CE-marking and product launch in Europe in 2012.
read more

Press Release 10/2011

Curetis AG attracts Forbion and Roche as new investors

Series A  financing round expanded to €34.1 million
read more

Press Release 10/2011

Curetis AG Opens Unyvero™ Cartridge Production Facility

Manufacturing capacity scalable to up to 1 Mio. cartridges per year.
read more

Press Release 5/2011

Curetis AG successfully increases Series A financing
round to EUR 24.5 million

Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, today announced an extension of its Series A financing, bringing the total size of the round to € 24.5 million. CD-Venture joined the funding as a new investor, while all of Curetis' existing VC investors participated in the round. Several private investors also continued to co-invest.
read more

Press Release 4/2011

Curetis AG and its Partners obtain Additional € 0.5 Million Funding under German Federal Innovation Grant Program

Federal funding for joint R&D project of Curetis AG (Holzgerlingen, Germany), Polytechnic Schmalkalden (Germany) and Contexo GmbH (Winterbach, Germany) towards mass production optimization of consumables for innovative infectious disease diagnostics.
read more

Press Release 12/2010

Curetis appoints Oliver Schacht as CEO

Curetis AG announces the appointment of Oliver Schacht (current CFO Epigenomics AG / CEO Epigenomics, Inc.) as CEO, effective 1^st April 2011.
read more

Press Release 7/2010

Curetis completes Supervisory Board and announces new CFO

Curetis AG announces the election of Oliver Schacht (Epigenomics AG) as new Supervisory Board Member. In addition, Anne Burger (MedVenture Partners) has been appointed as new CFO.
read more

Press Release 6/2010

Curetis AG increases Series A Financing to € 20 Million and receives ISO 13485 Certification

With a € 1.5 Mio Second Closing, Curetis has now increased its Series A financing round to € 20 Mio. This additional financing will enable Curetis to complete the development of its innovative diagnostic products through the market entry.
read more

Press Release 12/2009

Curetis AG: Development of products to effectively diagnose severe infections is secured until market entry.

A consortium of leading life-science venture capital funds invests € 18.5 million in the German medical diagnostics company Curetis AG. This financing will enable Curetis to complete development of its innovative diagnostic products through to market entry.
read more

Press Release 04/2009

This solution will save many lives

The joint project between the Institute of Medical Microbiology and Hygiene in Tübingen (Germany), the Natural and Medical Sciences Institute (NMI), Reutlingen (Germany) and start-up Curetis AG aims at the development of new diagnostic solutions to detect hospital-acquired infections.

read more